Breast cancer inhibiting diastereomeric diacetato [1,2-bis(4-fluorophenyl)ethylenediamine] platinum( II) derivatives: Synthesis and studies on the relationship between reactivity and antitumor activity 1

Inorganica Chimica Acta

Volumn 250, Issue 1-2 PART I, 1996, Pages 203-218

  Gust, Ronald ^a   Krauser, Rudolf ^a   Schmid, Beate ^a   Schönenberger, Helmut ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Acetato complexes; Antitumor activity; Chelating diamine complexes; Diastereomeric complexes; Platinum complexes

Indexed keywords

AMINES; BIOACTIVITY; CELL CULTURE; CELLS; CHLORINE COMPOUNDS; COORDINATION REACTIONS; DISEASES; DRUG DELIVERY; HYDROLYSIS; KINETIC THEORY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOPHILES; RATE CONSTANTS; SOLUBILITY; TUMORS;

ACETATO COMPLEXES; ANTI-TUMOR ACTIVITIES; CHELATING DIAMINES; DIASTEREOMERIC COMPLEXES; PLATINUM COMPLEXES;

PLATINUM COMPOUNDS;

EID: 0001685959     PISSN: 00201693     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0020-1693(96)05231-0     Document Type: Article

References (36)

1. B. Rosenberg, L. VanCamp and T. Krigas, Nature (London), 205 (1965) 698-699.
2. E. Günther and J. Engel, Pharm. Ztg., 138 (1993) 9-20.
3. F. Bernges, G. Dörner and E. Holler, Eur. J. Biochem., 191 (1990) 743-753.
4. R. Gust, G. Bernhardt, Th. Spruß, R. Krauser, M. Koch, H. Schonenberger, K.-H. Bauer, S. Schertl and Z. Lu, Arch. Pharm. (Weinheim), 328 (1995) 595-603.
5. J.J. Roberts, R.J. Knox, F. Friedlos and D.A. Lydall, in D.C.H. McBrien and T.F. Slater (eds.), Biochemical Mechanisms of Platinum Antitumor Drugs, IRL Press, Oxford, 1985, pp. 29-64.
6. L.H. Einhorn, E.D. Crawford, W.U. Shipley, P.J. Loehrer and S.D.Williams, in V.T. DeVita, Jr., S. Hellman and S.A. Rosenberg (eds.), Cancer Principles and Practice of Oncology, J.B. Lippincott, Philadelphia, PA, 1989, pp. 1071.
7. A.W. Prestayko, St.T. Crooke and St.K. Carter, Cisplatin - Current Status and New Developments, Academic Press, New York, 1980.
8. Z.H. Siddik, S.E. Dible, F.E. Boxall and K.R. Harrap, in D.C.H. McBrien and T.F. Slater (eds.), Biochemical Mechanisms of Platinum Antitumor Drugs, IRL Press, Oxford, pp. 171-198.
9. M. Koch, Ph.D. Thesis, University of Regensburg, Germany, 1993.
10. H. Schonenberger, in D. Schmähl and M. Peukert (eds.), Onkologie, Schattauer, Stuttgart, 1990.
11. H. Reile, G. Bernhardt, M. Koch, H. Schönenberger, M. Hollstein and F. Lux, Cancer Chemother. Pharmacol., 30 (1992) 113-122.
12. H.E. Wander and G.A. Nagel, Mammakarzinome, Zuckschwerdt, Munich, 1984.
13. K. Kolaric and D. Vukas, Cancer Chemother. Pharmacol., 27 (1991) 409-412
14. G. Cocconi, G. Bisagni, M. Bacchi, C. Boni, R. Bartolucci, G. Ceci, M.A. Colozza, V. De Lisi, R. Lottici and A.M. Mosconi, J. Clin. Oncol., 9 (1991) 664-669.
15. H. Reile, Th. Spruß, R. Müller, R. Gust, G. Bernhardt, H. Schönenberger and J. Engel, Arch. Pharm. (Weinheim), 323 (1990) 301-306.
16. M.J. Cleare, P.C. Hydes, D.R. Hepburn and B.W. Malerbi, in A.R. Prestayko, S.T. Crooke and S.K. Carter (eds.), Cisplatin - Current Status and New Developments, Academic Press, New York, 1980, p. 149.
17. R. Müller, R. Gust, M. Jennerwein, H. Reile, R. Laske, W. Krischke, G. Bernhardt, Th. Spruß, J. Engel and H. Schönenberger, Eur. J. Med. Chem., 24 (1989) 341-348.
18. A.A. Frost and A.R.G. Pearson, Kinetics and Mechanism, Wiley, New York, 1961.
19. T.G. Appleton, R.D. Berry, C.A. Davis, J.R. Hall and H.A. Kimlin, Inorg. Chem., 23 (1984) 3514-3521.
20. R. Gust, H. Schönenberger, J. Kritzenberger, K.-J. Range, U. Klement and T. Burgemeister, Inorg. Chem., 32 (1993) 5939-5950.
21. P.J. Bednarski and B. Trümbach, Transition Met. Chem., 19 (1994) 513-517.
22. R.J. Knox, F. Friedlos, D.A. Lydall and J.J. Roberts, Cancer Res., 46 (1986) 1972-1979.
23. P.J. Bednarski, J. Inorg. Biochem., 60 (1995) 1-19.
24. S.K. Mauldin, M. Plescia, F.A. Richard, S.D. Wyrick, R.D. Voyksner and S.G. Chaney, Biochem. Pharmacol., 37 (1988) 3321-3333.
25. S.L. Gonias and S.V. Pizzo, J. Biol. Chem., 258 (1983) 5764-5769.
26. P.C. Dedon and R.F. Borch, Biochem. Pharmacol., 36 (1987) 1955-1964.
27. T.G. Appleton, J. W. Conner, J.R. Hall and P.D. Prenzler, Inorg. Chem., 28 (1989) 2030-2037.
28. R.E. Norman, J.D. Ranford and P.J. Sadler, Inorg. Chem., 31 (1992) 877-888.
29. S.J. Berners-Price and P.W. Kuchel, J. Inorg. Biochem., 28 (1990) 305-326.
30. P.J. Bednarski, B. Trümbach, N.A. Kratochwil and H. Schönenberger, J. Med. Chem., 35 (1992) 4479-4485.
31. A.F. LeRoy and W.C. Thompson, J. Natl. Cancer Inst., 81 (1989) 427-436.
32. A.J. Repta and D.F. Long, in A.W, Prestayko, St.T. Crooke and St.K. Carter (eds.), Cisplatin - Current Status and New Developments, Academic Press, New York, 1980, pp. 285-304.
33. P.J. Bednarski, N.A. Kratochwil and A. Otto, Drug Metab. Dispos., 22 (1994) 419-427.
34. R. Krauser, Ph.D. Thesis, University of Regensburg, Germany, 1995.
35. P.J. Bednarski, Biochem. Pharmacol., 43 (1992) 2609-2620.
36. R. Müller, P.J. Bednarski and H. Schönenberger, Inorg. Chim. Acta, 195 (1992) 77-87.